Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
202 studies found for:    "Aplastic anemia"
Show Display Options
Rank Status Study
21 Completed Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Mycophenolate mofetil;   Drug: Cyclosporine
22 Completed
Has Results
Purine Analog-Based Conditioning in Patients With Severe Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Fludarabine;   Drug: Cyclophosphamide;   Drug: Antithymocyte Globulin
23 Active, not recruiting Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation in Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Antithymocyte Globulin;   Drug: Cyclophosphamide;   Drug: Fludarabine;   Radiation: Total Body Irradiation (TBI);   Procedure: Bone Marrow Transplant
24 Completed
Has Results
Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Campath-1H;   Drug: r-ATG;   Drug: CsA
25 Unknown  Haploidentical Stem Cell Transplantation for Children With Acquired Severe Aplastic Anemia
Condition: Acquired Aplastic Anemia
Interventions: Drug: Fludarabine;   Drug: Cyclophosphamide;   Biological: anti-thymocyte globulin;   Biological: filgrastim;   Radiation: Total body irradiation;   Procedure: CD3-depleted hematopoietic cell transplantation
26 Recruiting A Single-Arm Phase 2 Study With Optimized Standard Protocol for Severe Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Drug: rabbit ATG, Cyclosporine, Levamisole
27 Completed Stem Cell Mobilization Potential in Patients With Aplastic Anemia in Remission
Condition: Aplastic Anemia
Interventions: Drug: G-CSF;   Procedure: Apheresis
28 Not yet recruiting Optimizing Cord Blood and Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)
Condition: Severe Aplastic Anemia
Interventions: Drug: Antithymocyte Globulin;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Radiation: Total Body Irradiation (TBI);   Procedure: UCB HSCT;   Procedure: Haplo HSCT;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil (MMF);   Drug: G-CSF
29 Unknown  Mesenchymal Stem Cells Transplantation to Patients With Relapsed/Refractory Aplastic Anemia.
Condition: Aplastic Anemia
Intervention: Biological: bone marrow derived mesenchymal stem cells
30 Not yet recruiting ATG Combined With Cyclophosphamide And Cord Blood Transfusion in Treating Patients With Severe Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Rabbit ATG, (Genzyme);   Drug: Cy;   Drug: CsA;   Biological: Cord blood
31 Active, not recruiting A Phase 2 Study to Evaluate the Efficacy and Safety of AMG531 in Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Drug: AMG531
32 Terminated Randomized Study In Severe Aplastic Anemia Patients Receiving Atg, Cyclosporin A, With Or Without G-CSF (SAA-G-CSF)
Condition: Aplastic Anaemia
Interventions: Drug: G-CSF;   Drug: Early retreatment with ATG
33 Completed
Has Results
Anti-thymocyte Globulin and Cyclosporine as First-Line Therapy in Treating Patients With Severe Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: cyclosporine;   Other: flow cytometry;   Biological: anti-thymocyte globulin
34 Terminated Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood Transplant
Condition: Aplastic Anemia
Interventions: Radiation: total-body irradiation;   Drug: cyclophosphamide;   Biological: anti-thymocyte globulin;   Drug: cyclosporine;   Procedure: umbilical cord blood transplantation;   Drug: mycophenolate mofetil;   Procedure: bone marrow aspiration;   Genetic: DNA analysis;   Biological: filgrastim
35 Completed Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Anti-thymocyte globulin;   Drug: Cyclophosphamide;   Procedure: Bone marrow transplantation
36 Unknown  Reduced Toxicity Fludarabine (Flu) + Cyclophosphamide (CPM) + Rabbit Antithymocyte Globulin (rATG) Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia (SAA)
Condition: Aplastic Anemia
Intervention: Drug: Cyclophosphamide, Fludarabine, Thymoglobulin
37 Completed Cyclophosphamide and Anti-thymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing Donor Bone Marrow Transplant
Condition: Aplastic Anemia
Interventions: Drug: cyclophosphamide;   Biological: anti-thymocyte globulin;   Drug: cyclosporine;   Procedure: allogeneic bone marrow transplantation;   Drug: methotrexate;   Genetic: DNA analysis;   Other: flow cytometry;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis
38 Recruiting Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia
Condition: Severe Aplastic Anemia
Interventions: Drug: cyclosporine;   Procedure: Matched Unrelated Donor Hematopoietic Stem Cell Transplant;   Drug: horse anti-thymocyte globulin (ATG);   Drug: rabbit anti-thymocyte globulin (ATG);   Drug: methotrexate;   Drug: fludarabine;   Drug: cyclophosphamide;   Radiation: low-dose total body irradiation (TBI);   Procedure: Immunosuppressive Therapy (IST)
39 Unknown  Different Doses of Anti-thymocyte Globin to Treat Child Severe Aplastic Anemia
Condition: Severe Aplastic Anemia
Intervention: Drug: ATG
40 Withdrawn Reduced-Intensity Preparative Regimen for Allogeneic Stem Cell Transplantation in Patients With Severe Aplastic Anemia
Condition: Severe Aplastic Anemia
Intervention: Drug: Cyclophosphamide, Fludarabine, Rabbit ATG

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.